Primary Care

Neuro-Ophthalmology

Questions discussed in this category

How often and in what way do you monitor patients who are receiving teprotumumab (Tepezza) for thyroid eye disease?

What would you recommend for long term management of extensive dural venous sinus thrombosis (CVST) in young females when the only provoking risk factor is combined OCP?

Thrombophilia testing, including JAK2 is negative. When would you stop anticoagulation?

4 Answers available

How do you determine when to wean patients with idiopathic intracranial hypertension (IIH) off of acetazolamide?

3 Answers available

How do you make the decision to empirically treat for GCA when a patient is referred but cannot be immediately seen in clinic?

When a PCP calls with concern for GCA and is wondering whether to start empiric steroids what data do you prioritize to make that decision and do you ...

4 Answers available

Do you generally recommend low dose aspirin for patients with giant cell arteritis?

2 Answers available

Would you recommend medical therapy for asymptomatic idiopathic intracranial hypertension with completely normal visual field testing?

2 Answers available

How long do you continue steroid-sparing agents such as tocilizumab for GCA once the disease is in remission off steroids?

1 Answer available

Papers discussed in this category

Ann Intern Med, 2020 Sep 22

Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis : A Cohort Study.

Arthritis Rheum,

Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.

Archives of ophthalmology (Chicago, Ill. : 1960), 2010-06

Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale.

BMC musculoskeletal disorders, 2016-08-24

The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.

Stroke, 2023 Sep 07

Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis.

Stroke, 2024 Jan 29

Diagnosis and Management of Cerebral Venous Thrombosis: A Scientific Statement From the American Heart Association.

Primary Care

Neuro-Ophthalmology

Questions discussed in this category

Papers discussed in this category

Related Topics in Primary Care